Patents by Inventor Ekachai Jenwitheesuk

Ekachai Jenwitheesuk has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Optimized dengue virus entry inhibitory peptide (10AN)
    Patent number: 8637472
    Abstract: The invention relates peptide entry inhibitors and methods of determining such inhibitors that are bindable to regions of viruses having class II E proteins, such as the dengue virus E protein, as candidates for in vivo anti-viral compounds.
    Type: Grant
    Filed: July 11, 2008
    Date of Patent: January 28, 2014
    Assignees: University of Washington Through Its Center for Commercialization, Florida Gulf Coast University
    Inventors: Scott F. Michael, Sharon Isern, Joshua Costin, Vaikuntanath Samudrala, Ekachai Jenwitheesuk
  • Optimized dengue virus entry inhibitory peptide (DN81)
    Patent number: 8541377
    Abstract: The invention relates peptide entry inhibitors and methods of determining such inhibitors that are bindable to regions of viruses having class II E proteins, such as the dengue virus E protein, as candidates for in vivo anti-viral compounds.
    Type: Grant
    Filed: July 11, 2008
    Date of Patent: September 24, 2013
    Assignee: Florida Gulf Coast University
    Inventors: Scott F. Michael, Sharon Isern, Robert Garry, Ram Samudrala, Joshua Costin, Ekachai Jenwitheesuk
  • Compositions And Methods For Predicting Inhibitors Of Protein Targets
    Publication number: 20120142623
    Abstract: Compositions and methods are provided for predicting inhibitors of protein targets related to treatment of infectious disease, for example, bacterial, viral, or parasitic diseases. Methods are provided for predicting inhibitors of protein targets related to treatment infectious disease, for example, microbial disease, utilizing a docking with dynamics protocol to identify inhibitors, or utilizing a protein structure energy function to identify peptide or peptidomimetic inhibitors.
    Type: Application
    Filed: July 6, 2007
    Publication date: June 7, 2012
    Inventors: Michael Lagunoff, Wesley C. Van Voorhis, Ekachai Jenwitheesuk, Ram Samudrala
  • OPTIMIZED DENGUE VIRUS ENTRY INHIBITORY PEPTIDE (10AN)
    Publication number: 20110178003
    Abstract: The invention relates peptide entry inhibitors and methods of determining such inhibitors that are bindable to regions of viruses having class II E proteins, such as the dengue virus E protein, as candidates for in vivo anti-viral compounds.
    Type: Application
    Filed: July 11, 2008
    Publication date: July 21, 2011
    Applicant: FLORIDA GULF COAST UNIVERSITY
    Inventors: Scott F. Michael, Sharon Isern, Joshua Costin, Ram Samudrala, Ekachai Jenwitheesuk
  • OPTIMIZED DENGUE VIRUS ENTRY INHIBITORY PEPTIDE (DN81)
    Publication number: 20110112031
    Abstract: The invention relates peptide entry inhibitors and methods of determining such inhibitors that are bindable to regions of viruses having class II E proteins, such as the dengue virus E protein, as candidates for in vivo anti-viral compounds.
    Type: Application
    Filed: July 11, 2008
    Publication date: May 12, 2011
    Applicant: FLORIDA GULF COAST UNIVERSITY
    Inventors: Scott F. Michael, Sharon Isern, Robert Garry, Ram Samudrala, Joshua Costin, Ekachai Jenwitheesuk